Aiwu R He Selected Research

Fatigue

1/2018

Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aiwu R He Research Topics

Disease

11	Neoplasms (Cancer) 02/2024 - 04/2006
4	Adenocarcinoma 02/2024 - 05/2014
3	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 02/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 09/2023
2	Fibrosis (Cirrhosis) 01/2024 - 01/2022
1	Pathologic Complete Response 02/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Exanthema (Rash) 12/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2021
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Fatigue 01/2018
1	Hypertension (High Blood Pressure) 01/2009
1	Neoplasm Metastasis (Metastasis) 01/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 01/2022 - 12/2021
2	utomilumabIBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009 - 04/2006
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Protons (Proton)IBA 09/2023
1	Granzymes (Granzyme)IBA 01/2022
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	PerforinIBA 01/2022
1	B7-H1 AntigenIBA 12/2021
1	cobimetinibIBA 12/2021
1	atezolizumabIBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	ribociclibIBA 01/2020
1	Everolimus FDA Link 01/2020
1	Proteasome InhibitorsIBA 11/2019
1	Phosphotransferases (Kinase)IBA 11/2019
1	Lapatinib (GW572016)FDA Link 11/2019
1	Bortezomib (Velcade)FDA Link 11/2019
1	Transaminases (Aminotransferases)IBA 01/2018
1	kallistatinIBA 02/2015
1	SpectrinIBA 02/2015
1	Capecitabine (Xeloda)FDA Link 05/2014
1	Fluorouracil (Carac)FDA LinkGeneric 05/2014
1	ixabepilone (BMS 247550)FDA Link 12/2012
1	Bevacizumab (Avastin)FDA Link 01/2009
1	ErbB Receptors (EGF Receptor)IBA 04/2006

Therapy/Procedure

5	Therapeutics 09/2023 - 01/2009
2	Drug Therapy (Chemotherapy) 02/2024 - 01/2020
2	Immunotherapy 12/2022 - 01/2022
1	Radiotherapy 02/2024
1	Neoadjuvant Therapy 02/2024
1	Proton Therapy 09/2023
1	Liver Transplantation 12/2022
1	Precision Medicine 01/2022
1	Adjuvant Chemotherapy 05/2014